BVFL vs MRNA · P/E 15, rev $49.7M vs rev $145.0M
BV Financial, Inc. Common Stock (BVFL) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
BV Financial, Inc. Common Stock (BVFL) is a banks - regional company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported BVFL revenue for 2025-12-31 was $49.7M. Net income was $13.5M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BVFL currently screens at market cap $167.8M and trailing P/E 15.0.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
BVFL currently screens at market cap $167.8M and trailing P/E 15.0. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BVFL and MRNA stock pages for the full models.
Not investment advice.